Unlocking Potency Testing for Vaccine Development

[Article Title]

In the race to develop and bring to market safe and effective vaccines, potency testing is a critical checkpoint. Measuring a vaccine’s ability to elicit the desired immune response is not just a regulatory requirement, it is necessary for ensuring product efficacy and validating batch stability and consistency. Vaccine potency testing is a strategic lever that can affect everything from compliance and quality assurance to marketability and health impacts, making it an indispensable part of vaccine development and production.

In this white paper from Charles River Laboratories, learn more about potency testing in vaccine development and how partnering with an experienced CRO can help.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.